Country
United Kingdom
Less than a year after signing a lucrative licensing deal with Eli Lilly and Co, UK-based Evox Therapeutics Ltd has completed a Series C financing round to advance therapeutics based on exosomes into the clinic.
Full text available to subscribers only. Click here for information on subscribing to MedNous.